Insider filing · RCUS
Juan C. Jaen
President
profile →
Arcus Biosciences, Inc.
RCUS · Healthcare · 21 filings in 24 months
ticker →
Juan C. Jaen sold $2.0M of Arcus Biosciences (RCUS)
Executed Oct 28 2025, disclosed Oct 30 2025, 2 days later.
Value, as filed
$2.0M
96,059 sh across 3 lots
Executed
Oct 28 2025
the trade date, as filed
Disclosed
Oct 30 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JJJuan C. Jaen (President) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Arcus Biosciences, Inc. (RCUS). The largest single filing was $2.1M of RCUS (82,997 sh × $24.71, as filed), executed Dec 4 2025.
The name
RCUSHealthcare · Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Juan C. Jaen in RCUS
RCUSSALE
Arcus Biosciences, Inc.
$2.0M68,301 sh across 2 lots
Exec Jul 9
Filed Jul 13 · 5:36 PM ET RCUSSALE Arcus Biosciences, Inc. $830K
29,734 sh across 3 lots
Exec Jun 22
Filed Jun 24 · 5:30 PM ET RCUSSALE Arcus Biosciences, Inc. $633K
29,670 sh × $21.34
Exec Jan 5
Filed Jan 7 · 5:30 PM ET RCUSSALE Arcus Biosciences, Inc. $467K
21,208 sh across 2 lots
Exec Dec 16 2025
Filed Dec 18 2025 · 5:30 PM ET RCUSSALE Arcus Biosciences, Inc. $2.1M
82,997 sh × $24.71
Exec Dec 4 2025
Filed Dec 5 2025 · 5:30 PM ET RCUSSALE Arcus Biosciences, Inc. $913K
44,950 sh across 2 lots
Exec Nov 17 2025
Filed Nov 19 2025 · 5:30 PM ET